| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.2 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |